Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases

Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases

Nanomedicine is emerging as a groundbreaking strategy for the management of the neuro-visual symptoms of neuroinflammatory and neurodegenerative diseases. This innovative field of study leverages nanoscale materials and technologies to improve drug delivery, enabling targeted treatments to reach the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Georgia Savvidou, Ellas Spyratou, Maria-Eleni Zachou, Efstathios P. Efstathopoulos
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Series:	Journal of Nanotheranostics
Subjects:	neuro-ophthalmology neurodegenerative diseases neuroinflammatory diseases nanotechnology nanomedicine
Online Access:	https://www.mdpi.com/2624-845X/6/1/6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nanomedicine breakthroughs in cancer and neurodegenerative disease therapy
by: Abdul Haque, et al.
Published: (2025-01-01)

Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
by: Maroua Jalouli, et al.
Published: (2025-01-01)

Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
by: Neevashini Chengebroyen, et al.
Published: (2025-07-01)

Correction: Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
by: Neevashini Chengebroyen, et al.
Published: (2025-08-01)

Efficacy versus Toxicity - The Ying and Yang in Translating Nanomedicines
by: Sahadev A Shankarappa, et al.
Published: (2014-09-01)

Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases
by: Adriana Jiménez, et al.
Published: (2025-02-01)

Polymeric Nanomedicines in Diabetic Wound Healing: Applications and Future Perspectives
by: Chen Z, et al.
Published: (2025-05-01)

Natural Neuroinflammatory Modulators: Therapeutic Potential of Fungi-Derived Compounds in Selected Neurodegenerative Diseases
by: Agnieszka Godela, et al.
Published: (2025-07-01)

Ocular Manifestations in Patients with Sensorineural Hearing Loss
by: Haniah A. Zaheer, et al.
Published: (2022-11-01)

Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases
by: Lin X, et al.
Published: (2025-07-01)

Antiviral nanomedicine: Advantages, mechanisms and advanced therapies
by: Yicheng Pu, et al.
Published: (2025-10-01)

The Nanomedicine Revolution
by: Wasim Alamgir, et al.
Published: (2023-04-01)

Artificial Intelligence-Based Methodologies for Early Diagnostic Precision and Personalized Therapeutic Strategies in Neuro-Ophthalmic and Neurodegenerative Pathologies
by: Rahul Kumar, et al.
Published: (2024-12-01)

An overview of the feasibility of nanomedicine in pancreatic cancer theranostics
by: Kyriakos Kokkinogoulis, et al.
Published: (2025-06-01)

Neuro-Ophthalmology – An Approach to Common Cases in the Outpatient Department
by: Shalin Shah, et al.
Published: (2023-10-01)

CMPK2 promotes microglial activation through the cGAS-STING pathway in the neuroinflammatory mechanism
by: Feng Gao, et al.
Published: (2025-04-01)

Novel Isatin–Chalcone Hybrid Molecules: Design, Synthesis and Anti-Neuroinflammatory Activity Evaluation
by: Rongrong Wang, et al.
Published: (2025-03-01)

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
by: Bruno Lopes Santos-Lobato, et al.
Published: (2023-05-01)

The Science of Memory Loss: Insights into Alzheimer’s Disease
by: Agnieszka Starzyk, et al.
Published: (2025-02-01)

Inflammasomes in neuroinflammatory and neurodegenerative diseases
by: Sofie Voet, et al.
Published: (2019-04-01)

Advances in the development of nanomedicines for treating chronic kidney disease
by: He Yu-han, et al.
Published: (2025-06-01)

Pediatric Neuroimaging of Multiple Sclerosis and Neuroinflammatory Diseases
by: Chloe Dunseath, et al.
Published: (2024-12-01)

Anti-Neuroinflammatory Eremophilane Sesquiterpenoids from Marine-Derived Fungus <i>Phoma</i> sp. DXH009
by: Guanyu Yang, et al.
Published: (2025-02-01)

Melatonin—A Powerful Antioxidant in Neurodegenerative Diseases
by: Renata Kołodziejska, et al.
Published: (2025-07-01)

Integrated Metabolomics and Transcriptomics Analyses Reveal Metabolic Changes in Primary Angiitis of the Central Nervous System
by: Lu P, et al.
Published: (2025-02-01)

Neuroinflammatory disorders of the central nervous system associated with monkeypox virus: a systematic review and call to action
by: Shramana Deb, et al.
Published: (2025-02-01)

Inflammasomes in neurodegenerative diseases
by: Qianchen Wang, et al.
Published: (2024-12-01)

From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
by: Elisa Duranti, et al.
Published: (2024-09-01)

Nanotechnology’s Impact on Revolutionizing Healthcare and Drug Delivery in the 21st Century
by: Trivedi Udit, et al.
Published: (2025-01-01)

Nanomedicines for the treatment of genitourinary neoplasms
by: Shaowen Wang, et al.
Published: (2025-10-01)

Metachromatic Leukodystrophy Presenting with Multiple Cranial Nerve and Lumbosacral Nerve Root Enhancement Without White Matter Changes
by: Ruben Jauregui, et al.
Published: (2025-02-01)

Nanomedicine: Pioneering Advances in Neural Disease, Stroke and Spinal Cord Injury Treatment
by: Borish Loushambam, et al.
Published: (2025-02-01)

Frontier applications of retinal nanomedicine: progress, challenges and perspectives
by: Zhimin Tang, et al.
Published: (2025-02-01)

Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept)
by: Natália Cristina Gomes-da-Silva, et al.
Published: (2025-05-01)

The Transformative Role of Nanotechnology in the Management of Diabetes Mellitus: Insights from Current Research
by: Natalia G. Vallianou, et al.
Published: (2025-05-01)

Editorial: Neuroinflammation and neurodegenerative diseases
by: Pradeep Kumar, et al.
Published: (2025-02-01)

Neuron-specific enolase and Tau protein as biomarkers for sepsis-associated delirium: a cross-sectional pilot study
by: Agnes Araújo Sardinha Pinto, et al.
Published: (2025-04-01)

The Effect of Bioactive Compounds in Multiple Sclerosis as the Adjuvant Immunomodulatory: A Comprehensive Review
by: Mathiyazhagan Narayanan, et al.
Published: (2025-07-01)

Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
by: Yinghui Li, et al.
Published: (2024-12-01)

Peripheral dysfunctions in neurodegenerative diseases: Mechanisms and contribution to pathogenesis
by: M.A. Mukhamedyarov, et al.
Published: (2018-12-01)